FAIR Health is launching a new website this week aimed at informing older adults and their caregivers about treatment options, including tools related to cost, quality, and shared decision-making.
FAIR Health is launching a new website this week aimed at informing older adults and their caregivers about treatment options, including tools related to cost, quality, and shared decision-making.
The national, independent nonprofit said the section includes information about navigating insurance and improving financial literacy.
Shared decision making, said Robin Gelburd, JD, president of FAIR Health, “involves a conversation between the provider and the patient or the caregiver on behalf of the patient about different treatment options and care to elicit the patient’s preferences and values, which would then allow the patient to choose a clinical pathway that meets those needs.”
There are 5 shared decision-making tools for patients to use when faced with early-stage breast cancer, hip osteoarthritis, hip replacement, spinal stenosis, or fast-growing prostate cancer. The tools combine clinical and cost information linked with different treatment options.
In an interview with The American Journal of Managed Care®, Gelburd said the 5 conditions were picked on the basis of the volume seen in the organization’s database of 38 billion billed procedures, as well as from the different focus groups the organization conducted with patients, caregivers, providers, and subject matter experts.
The 3 conditions added to the cost tool—Alzheimer disease/dementia, heart failure, and major depression—are particularly relevant to older adults, she said. The tool returns estimates based on geographic location for in-network and out-of-network services.
In addition to the tools, the newly created Older Adult section adds content about the conditions, a section on financial health literacy, checklists with suggested questions to ask providers during visits, and links to related external resources.
Gelburd said the website is different from other existing consumer-oriented ones.
“As far as we know, we’re the first that pairs the rigor of the clinical offerings and pathways with the rich cost information that we have in our repository; there are none that we are aware of that really link at the procedure level, the different cost components from an in- and out-of-network perspective, with those clinical decision aids."
The organization’s first shared decision-making tool targeted palliative care, with information about nutritional assistance, breathing assistance, and dialysis.
The project was funded by The John A. Hartford Foundation.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
2 Commerce Drive
Cranbury, NJ 08512